{"transactions":[{"id":2105366,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":117098,"kind":"organization","name":"Accelmed Partners II L.P.","position":1,"cik":"0001807256","reported_name":"Accelmed Partners II L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-11-23T17:29:37.000Z","date":"2022-11-22","kind":"purchase","acquired":true,"shares":62398,"price":1.499,"value":93534.602,"ownership":{"direct":true},"balance_after":4432948,"source":{"system":"sec-edgar","filing":"0000899243-22-036949","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1807256/000089924322036949/doc4.xml","form_type":"4"}},{"id":2105365,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":117098,"kind":"organization","name":"Accelmed Partners II L.P.","position":1,"cik":"0001807256","reported_name":"Accelmed Partners II L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-11-23T17:29:37.000Z","date":"2022-11-21","kind":"purchase","acquired":true,"shares":327893,"price":1.499,"value":491511.607,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Shares are held by Accelmed Partners II LP. Accelmed Partners II, LLC (\"Accelmed LLC\") is the general partner of Accelmed Partners II GP, L.P., which is the general partner of Accelmed Partners II LP. Uri Geiger is the managing partner of Accelmed LLC and has sole voting and dispositive power with respect to the shares held by Accelmed Partners II LP. Dr. Uri Geiger is the Managing Partner of Accelmed LLC. The address of each of Accelmed Partners II GP, LP and Accelmed Partners II LP is Ugland House, South Church Street, PO Box 309, Grand Cayman KY1-1104, Cayman Islands."}],"balance_after":4370550,"source":{"system":"sec-edgar","filing":"0000899243-22-036949","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807256/000089924322036949/doc4.xml","form_type":"4"}},{"id":2739711,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":117098,"kind":"organization","name":"Accelmed Partners II L.P.","position":1,"cik":"0001807256","reported_name":"Accelmed Partners II L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B' Preferred Stock","published_at":"2021-04-26T17:18:15.000Z","date":"2021-04-26","kind":"exercise","acquired":true,"shares":3454422,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each share of Preferred Stock automatically converted on a 1-for-1 basis into Common Stock upon the closing of the Issuer's initial public offering, for no additional consideration. The Preferred Stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each share of Preferred Stock automatically converted on a 1-for-1 basis into Common Stock upon the closing of the Issuer's initial public offering, for no additional consideration. The Preferred Stock has no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Shares are held by Accelmed Partners II LP.  Accelmed Partners II, LLC (\"Accelmed LLC\") is the general partner of Accelmed Partners II GP, L.P., which is the general partner of Accelmed Partners II LP. Uri Geiger is the managing partner of Accelmed LLC and has sole voting and dispositive power with respect to the shares held by Accelmed Partners II LP. Mr. Norton, a member of our board of directors, is a General Partner at Accelmed LLC. The address of each of Accelmed LLC, Accelmed Partners II GP, LP, Accelmed Partners II LP and Mr. Norton is Ugland House, South Church Street, PO Box 309, Grand Cayman KY1-1104, Cayman Islands."}],"balance_after":3454422,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3454422},"source":{"system":"sec-edgar","filing":"0001209191-21-028327","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1807256/000120919121028327/doc4.xml","form_type":"4"}},{"id":2739710,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":117098,"kind":"organization","name":"Accelmed Partners II L.P.","position":1,"cik":"0001807256","reported_name":"Accelmed Partners II L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-04-26T17:18:15.000Z","date":"2021-04-26","kind":"exercise","acquired":true,"shares":3454422,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Shares are held by Accelmed Partners II LP.  Accelmed Partners II, LLC (\"Accelmed LLC\") is the general partner of Accelmed Partners II GP, L.P., which is the general partner of Accelmed Partners II LP. Uri Geiger is the managing partner of Accelmed LLC and has sole voting and dispositive power with respect to the shares held by Accelmed Partners II LP. Mr. Norton, a member of our board of directors, is a General Partner at Accelmed LLC. The address of each of Accelmed LLC, Accelmed Partners II GP, LP, Accelmed Partners II LP and Mr. Norton is Ugland House, South Church Street, PO Box 309, Grand Cayman KY1-1104, Cayman Islands."}],"balance_after":4042657,"source":{"system":"sec-edgar","filing":"0001209191-21-028327","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807256/000120919121028327/doc4.xml","form_type":"4"}},{"id":2740994,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":117098,"kind":"organization","name":"Accelmed Partners II L.P.","position":1,"cik":"0001807256","reported_name":"Accelmed Partners II L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-04-23T19:44:48.000Z","date":"2021-04-21","kind":"purchase","acquired":true,"shares":588235,"price":17,"value":9999995.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects shares purchased from the underwriters in the Companys initial public offering."}],"balance_after":588235,"source":{"system":"sec-edgar","filing":"0001209191-21-028192","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807256/000120919121028192/doc4.xml","form_type":"4"}}]}